Patents by Inventor David T. Miyamoto

David T. Miyamoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnosis and monitoring treatment of prostate cancer
    Patent number: 11079383
    Abstract: Provided herein are assays and methods related to determining a ratio of expression levels of PSA/PSMA or determining the expression level of PSMA in circulating tumor cells for diagnosis and/or for the purpose of monitoring treatment efficacy for prostate cancers that are likely hormone resistant.
    Type: Grant
    Filed: August 21, 2017
    Date of Patent: August 3, 2021
    Assignee: THE GENERAL HOSPITAL CORPORATION
    Inventors: Daniel A. Haber, Shyamala Maheswaran, David T. Miyamoto
  • DIAGNOSIS AND MONITORING TREATEMENT OF PROSTATE CANCER
    Publication number: 20170350896
    Abstract: Provided herein are assays and methods related to determining a ratio of expression levels of PSA/PSMA or determining the expression level of PSMA in circulating tumor cells for diagnosis and/or for the purpose of monitoring treatment efficacy for prostate cancers that are likely hormone resistant.
    Type: Application
    Filed: August 21, 2017
    Publication date: December 7, 2017
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Daniel A. HABER, Shyamala MAHESWARAN, David T. MIYAMOTO
  • Diagnosis and monitoring treatment of prostate cancer
    Patent number: 9766244
    Abstract: Provided herein are assays and methods related to determining a ratio of expression levels of PSA/PSMA or determining the expression level of PSMA in circulating tumor cells for diagnosis and/or for the purpose of monitoring treatment efficacy for prostate cancers that are likely hormone resistant.
    Type: Grant
    Filed: July 1, 2013
    Date of Patent: September 19, 2017
    Assignee: THE GENERAL HOSPITAL CORPORATION
    Inventors: Daniel A. Haber, Shyamala Maheswaran, David T. Miyamoto
  • DIAGNOSIS AND MONITORING TREATMENT OF PROSTRATE CANCER
    Publication number: 20150168413
    Abstract: Provided herein are assays and methods related to determining a ratio of expression levels of PSA/PSMA or determining the expression level of PSMA in circulating tumor cells for diagnosis and/or for the purpose of monitoring treatment efficacy for prostate cancers that are likely hormone resistant.
    Type: Application
    Filed: July 1, 2013
    Publication date: June 18, 2015
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Daniel A. Haber, Shyamala Maheswaran, David T. Miyamoto